Search research articles
Contact Us
Filters
Showing results (21-30 of 551) with videos related to
Page
of 56
Sort By:
Cells
|
January 20, 2021
Detecting Resistance to Therapeutic ALK Inhibitors in Tumor Tissue and Liquid Biopsy Markers: An Update to a Clinical Routine Practice
Paul Hofman
Journal of Thoracic Disease
|
February 19, 2019
The challenges of evaluating predictive biomarkers using small biopsy tissue samples and liquid biopsies from non-small cell lung cancer patients
Paul Hofman
Current Opinion in Oncology
|
December 2, 2016
Liquid biopsy for early detection of lung cancer
Paul Hofman
Journal of Thoracic Disease
|
April 19, 2019
PD1/PD-L1 inhibitor treatment for late stage non-small cell lung carcinoma, sometimes…does more harm than good!
Paul Hofman
The Journal of Liquid Biopsy
|
March 3, 2025
Implementation of the clinical practice of liquid biopsies for thoracic oncology the experience of the RespirERA university hospital institute (Nice, France)
Paul Hofman
Journal of Thoracic Disease
|
June 28, 2019
Toward precision medicine based on the molecular landscape of carcinoma <i>in situ</i> of the bronchus: is it realistic for patients with pre-invasive lung disease?
Paul Hofman
Annales De Pathologie
|
February 4, 2019
[Thoracic oncology and tumor mutational burden: Towards new challenges for the pathologist?]
Paul Hofman
Revue Francophone Des Laboratoires : RFL
|
January 13, 2021
[Management of samples in pathology laboratories and biobanks during the Covid-19 pandemic]
Paul Hofman
Translational Oncology
|
July 6, 2023
Matched tissue and liquid biopsies for advanced non-small cell lung cancer patients A potentially indispensable complementary approach
Paul Hofman
Cancer Cytopathology
|
October 2, 2020
Liquid biopsy for lung cancer screening: Usefulness of circulating tumor cells and other circulating blood biomarkers
Paul Hofman
Page
of 56
Search research articles
Search
Showing results (21-30 of 551) with videos related to
Sort By:
Page
of 56
Cells
|
January 20, 2021
Detecting Resistance to Therapeutic ALK Inhibitors in Tumor Tissue and Liquid Biopsy Markers: An Update to a Clinical Routine Practice
Paul Hofman
Journal of Thoracic Disease
|
February 19, 2019
The challenges of evaluating predictive biomarkers using small biopsy tissue samples and liquid biopsies from non-small cell lung cancer patients
Paul Hofman
Current Opinion in Oncology
|
December 2, 2016
Liquid biopsy for early detection of lung cancer
Paul Hofman
Journal of Thoracic Disease
|
April 19, 2019
PD1/PD-L1 inhibitor treatment for late stage non-small cell lung carcinoma, sometimes…does more harm than good!
Paul Hofman
The Journal of Liquid Biopsy
|
March 3, 2025
Implementation of the clinical practice of liquid biopsies for thoracic oncology the experience of the RespirERA university hospital institute (Nice, France)
Paul Hofman
Journal of Thoracic Disease
|
June 28, 2019
Toward precision medicine based on the molecular landscape of carcinoma <i>in situ</i> of the bronchus: is it realistic for patients with pre-invasive lung disease?
Paul Hofman
Annales De Pathologie
|
February 4, 2019
[Thoracic oncology and tumor mutational burden: Towards new challenges for the pathologist?]
Paul Hofman
Revue Francophone Des Laboratoires : RFL
|
January 13, 2021
[Management of samples in pathology laboratories and biobanks during the Covid-19 pandemic]
Paul Hofman
Translational Oncology
|
July 6, 2023
Matched tissue and liquid biopsies for advanced non-small cell lung cancer patients A potentially indispensable complementary approach
Paul Hofman
Cancer Cytopathology
|
October 2, 2020
Liquid biopsy for lung cancer screening: Usefulness of circulating tumor cells and other circulating blood biomarkers
Paul Hofman
Page
of 56